8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-22-012039
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cpix-20220503.htm…